secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2024-05-20T23:59:59+00:00
Accession:  0001193125-24-142950
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya receives $5M strategic investment from ADDF for COYA 302 FTD trial
-----------------------------------------------------------------------

- ADDF purchased 603,136 shares at $8.29/share for $5M gross proceeds in private placement.
- Funds will support COYA 302 development for frontotemporal dementia (FTD) Phase 2 trial.
- ADDF, focused on Alzheimer's and related dementias, backs combination therapy approach.
- Registration statement for resale of shares to be filed within 30 days and effective within 75 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312524142950/0001193125-24-142950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312524142950/d820823d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-142950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer